FDA welcomes Committee on Standards in Public Life recommendations for Ministerial Code reform

FDA General Secretary Dave Penman welcomed the “comprehensive report” from the Committee on Standards in Public Life on Upholding Standards in Public Life, saying it details “where urgent action is needed to restore public faith in those either elected or appointed to serve the public’s interests”.
Penman argued that the report’s nine recommendations on the Ministerial Code “could not come at a more opportune time”, with the FDA’s recent survey of members showing that 85% of senior civil servants – those working closest to ministers – had no faith in the code as a means of regulation of ministerial behaviour.
He also told the Guardian that “there can be no hiding from the fact that the current Prime Minister has undermined confidence in the Ministerial Code as a meaningful regulator of ministerial conduct”, but pointed out that existing arrangements already fell short of the independence required to be effective:
“As the committee recognises, the independent process that has now been established in Parliament, whilst far from perfect, provides a model for the approach that the public can rightly expect to regulating and enforcing standards on those they elect to serve their interests.”
Related News
-

“An outstanding leader with a proven track record” – FDA responds to Dame Antonia Romeo appointment
The FDA has welcomed the appointment of former Home Office Permanent Secretary Dame Antonia Romeo as Cabinet Secretary, following the departure of Sir Chris Wormald last week.
-

“New low” for government’s relationship with civil service – FDA responds following departure of Cabinet Secretary Chris Wormald
The FDA has responded to the announcement that Sir Chris Wormald has departed the role of Cabinet Secretary, with FDA General Secretary Dave Penman describing it as a “new low” for the government’s relationship with the civil service.
-

“Farcical” to wait until 2030 to make decision on restoration and renewal of parliament, says FDA
The FDA has responded to the latest publication of UK Parliament’s Restoration and Renewal Board, ‘Delivering restoration and renewal of the Palace of Westminster: the costed proposals.’